Suppr超能文献

阿育吠陀疗法治疗新冠肺炎:一例病例报告。

Ayurvedic treatment of COVID-19: A case report.

作者信息

Girija P L T, Sivan Nithya

机构信息

Sanjeevani Ayurveda and Yoga Centre, India.

Sanjeevani Ayurveda and Yoga Centre, India.

出版信息

J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100329. doi: 10.1016/j.jaim.2020.06.001. Epub 2020 Jun 19.

Abstract

This is the first known case of a Coronavirus disease (COVID-19) positive patient treated entirely with Ayurveda. So far in Modern Western Medicine (MWM), no cure has been found which is specific to COVID-19. The only literature relevant to the treatment of Coronavirus disease has surfaced from Traditional Chinese Medicine (TCM). TCM which was extensively used to control the epidemic in China, also consists of herbal medicines similar to Ayurveda. In this case, the patient, who was familiar with the use of Ayurvedic medicines, fully aware that no proven cure exists in MWM, decided to entirely rely on the limited Ayurvedic medicines that he had in his possession at the time of falling ill. Despite the patient presenting with symptoms, namely high fever, severe body pain and severe cough, along with many of the other associated symptoms of COVID-19, the progress of the disease could be arrested within a short period by being exclusively on Ayurvedic medicines. This illustrates that there is a wide scope to explore the variety of pertinent medicines present in Ayurvedic pharmacopoeia which can be used more rationally to suit every stage of the disease. Being the first-of-its-kind it is a valuable contribution to scientific literature from the world of Ayurveda. This should encourage the healthcare policy makers to quickly use Ayurveda to bring the COVID-19 pandemic under control in India, as they seemed to have demonstrated it in China with TCM.

摘要

这是首例已知的完全采用阿育吠陀医学治愈的新型冠状病毒肺炎(COVID-19)阳性患者。到目前为止,现代西医尚未找到针对COVID-19的特效疗法。唯一与冠状病毒病治疗相关的文献来自中医。中医在中国被广泛用于控制疫情,其也包含与阿育吠陀医学类似的草药。在此病例中,该患者熟悉阿育吠陀药物的使用,深知现代西医中不存在已证实的治愈方法,于是决定完全依靠生病时自己所拥有的有限的阿育吠陀药物。尽管患者出现了高热、严重身体疼痛、剧烈咳嗽等症状,以及许多其他COVID-19相关症状,但仅通过使用阿育吠陀药物,病情在短时间内就得到了控制。这表明,探索阿育吠陀药典中各种相关药物具有广阔的空间,这些药物可以更合理地用于适应疾病的各个阶段。作为同类中的首个案例,这是阿育吠陀医学领域对科学文献的一项宝贵贡献。这应该会促使医疗政策制定者迅速采用阿育吠陀医学来控制印度的COVID-19疫情,就像他们在中国利用中医所展示的那样。

相似文献

1
Ayurvedic treatment of COVID-19: A case report.阿育吠陀疗法治疗新冠肺炎:一例病例报告。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100329. doi: 10.1016/j.jaim.2020.06.001. Epub 2020 Jun 19.
4
Management of w.s.r to COVID-19 - Case report.新型冠状病毒肺炎相关白塞病的管理——病例报告
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100416. doi: 10.1016/j.jaim.2021.02.007. Epub 2021 Mar 6.
6
Ayurvedic evaluation and treatment of Covid 19: A case report.阿育吠陀医学对新冠病毒19的评估与治疗:一例病例报告。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100489. doi: 10.1016/j.jaim.2021.07.005. Epub 2021 Jul 14.
7
Development of Ayurveda - Tradition to trend.阿育吠陀的发展——传统到潮流。
J Ethnopharmacol. 2017 Feb 2;197:10-24. doi: 10.1016/j.jep.2016.09.024. Epub 2016 Sep 12.

引用本文的文献

1
Ayurvedic and Chinese Herbs against Coronaviruses.草药对抗冠状病毒:阿育吠陀和中药。
Curr Pharm Des. 2024;30(21):1681-1698. doi: 10.2174/0113816128269864231112094917.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验